Video

Looking Out for Side Effects in Immunotherapy Combination Treatment

Immunotherapy in combination with chemotherapy is becoming a popular treatment for patients with lung cancer, but patients need to understand the side effects.

Immunotherapy in combination with chemotherapy brings on more side effects during treatment, however, serious side effects in combination treatment remain similar to side effects in chemotherapy alone, according to Nagashree Seetharamu, MD, MBBS.

At the CURE® Patient-Focused Sessions at the New York Lung Cancers Symposium® Seetharamu, associate professor in Clinical Medicine at Hofstra and Northwell Health, presented on the benefits and challenges for immunotherapy and chemotherapy combination treatment for patients with lung cancer. Seethearamu also sat with CURE to discuss the side effect realities of this combination treatment and why patients must remain vigilant as they undergo the combination therapy.

TRANSCRIPTION

You have immunotherapy with its own set of side effects. They're not overlapping, meaning that they don't cause the same type of side effects, for the most part, the immunotherapy causes side effects by an overactive immune system. When the immune cells that we are trying to activate or trying to get stronger to attack the cancer cells, may sometimes attack one's own body, that's where the side effects come.

When you do the two together, the side effects are numerically more, but the serious side effects are not that very different in the two groups, patients receiving chemotherapy alone versus patients receiving chemotherapy plus immunotherapy.

The one message I give to patients on immunotherapy, whether by itself or in combination with chemotherapy, is to make a note of anything that is not normal for them from the time they start the treatment. If there is anything new that happens, I don't want them to be guessing whether is it a side effect? Or is it something that I ate yesterday? I would not want them to guess, I want them to give the information to me and let me do the guessing because these side effects with immunotherapy are reversible if it's tackled in a timely fashion.

Related Videos
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Bald Doctor.
Dr. Anna Arthur is the Director of the Medical Nutrition Science Program, as well as a tenure-track Assistant Professor in the Department of Dietetics and Nutrition at the University of Kansas Medical Center.
Dr. Ritu Salani, the Director of Gynecologic Oncology at the University of California, Los Angeles (UCLA), UCLA Health, and a board-certified gynecologic oncologist.
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
Image of Dr. Braun.
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Michael Bogenschutz